Abhinav Deol, M.D.

Specialties

Oncology - Hematology, Oncology - Medical

Subspecialties

Malignant Hematology, Bone Marrow Transplant

Board Certification

American Board of Internal Medicine

Multidisciplinary Team

Locations

Karmanos Cancer Center
4100 John R
Detroit, MI 48201
Get Directions

Phone:1-800-KARMANOS

Call For Appointment

Podcast: Listen

Cancers Treatments

Locations

Karmanos Cancer Center

4100 John R
Detroit, MI 48201
Get Directions

Phone:1-800-KARMANOS

Get Directions

Education

Cancers Treatments

Clinical Trials

A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC-100 and Propranolol with and Without G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase II

Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase I/II

A Phase 1 Study Evaluating SC291, a Hypoimmune, Allogeneic CD19-directed CAR T Cell Therapy, in Relapsed and/or Refractory B-cell Malignancies (ARDENT)

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase I

A Phase 1 Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory B-Cell Lymphoma

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase I

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
N/A

A Phase II Study of CART-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase II

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase II

A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA versus Bortezomib, Lenalidomide and Dexamethasone (VRd) fo

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase III

Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
Phase II

Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel That is Nonconforming for Commercial Release

Cancer Category
Hematologic (Blood Cancers)
Age Group
Adult
Phase
N/A

Additional Info

Related News

March 15, 2024
IN THE NEWS – Chronic Myeloid Leukemia Symptoms: All the Medical Signs

Patient Power Chronic myeloid leukemia (CML) affects the blood and bone marrow. Abhinav Deol, M.D. , hematologist, medical oncologist, and member of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, explained how CML forms and the types of symptoms patients may face if their CML is in the chronic phase. Read the article here .
Read More
September 22, 2023
IN THE NEWS - My multiple myeloma won't respond to treatment: Now what?

Patient Power Abhinav Deol, M.D. , and Andrew Kin, M.D. , both hematologists and medical oncologists and members of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, explain the possible treatment options for multiple myeloma patients whose disease may have relapsed. Read the article here . Abhinav Deol, M.D. Andrew Kin, M.D.
Read More
September 15, 2023
New book for clinical providers fills a critical gap in care of hematopoietic stem cell transplant patients

A new textbook for clinical providers combining the expertise of pulmonologists, intensivists, and oncologists highlights the scholarship and important scientific contributions of several Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) faculty members and fellows. Ayman Soubani, M.D. , pulmonologist, service chief of Pulmonary and Critical Care, member of the Bone Marrow and Stem Cell Transplant and Thoracic Oncology Multidisciplinary Teams (MDTs) at Karmanos, professor of Interna...
Read More

Awards

2005-2006 Resident of the Year Award, Harper University Hospital, Detroit
2006 Award for Excellence in Geriatrics, Detroit Receiving Hospital
2009 American Society of Hematology Travel Grant, Annual Meeting, New Orleans

Professional Memberships

American Society of Clinical Oncology
American Society of Hematology
American Society of Blood an Marrow Transplantation

Publications

Deol A, Lum LG. Role of Donor Lymphocyte Infusion in Relapsed Hematological Malignancies after stem cell transplantation revisited. Cancer Treat Rev. 2010 Nov; 36(7):528-38
Deol A, Ratanatharathorn V, Uberti JP. Pathophysiology, prevention, and treatment of acute graft-versus-host disease. Transplant Research and Risk Management. 2011; 3:1-14
Deol A, Srideve Pitta, Ghadai M. Is pneumocystis carinii pneumonia the only cause of hypoxia in acquired immunodeficiency syndrome: A case report. ACP Michigan Chapter Scientific Meeting, Traverse City, MI. September, 2004
Deol A, Janeline Daubert, Liu L. Incidence of hemoptysis as a resenting complaint in sarcoidosis: A case report and review of literature. First Annual AMA-RFS Meeting. Atlanta, GA. December 2004
Mohammad T. Deol A, Atwal G, Dache T. Erroneous blood cultures: Cost to the system. Continuous Quality Improvement Project. October 2004

Provider Profile:
Abhinav Deol, M.D.

Abhinav Deol, M.D.

Cancers Treated

Locations

Karmanos Cancer Center

Education

School

Residency

Fellowships

Clinical Trials

A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC-100 and Propranolol with and Without G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation

A Phase 1 Study Evaluating SC291, a Hypoimmune, Allogeneic CD19-directed CAR T Cell Therapy, in Relapsed and/or Refractory B-cell Malignancies (ARDENT)

A Phase 1 Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory B-Cell Lymphoma

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma

A Phase II Study of CART-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA versus Bortezomib, Lenalidomide and Dexamethasone (VRd) fo

Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release

Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel That is Nonconforming for Commercial Release

Additional Info

Related News

IN THE NEWS – Chronic Myeloid Leukemia Symptoms: All the Medical Signs

IN THE NEWS - My multiple myeloma won't respond to treatment: Now what?

New book for clinical providers fills a critical gap in care of hematopoietic stem cell transplant patients

OncLive On Air - Dr. Deol on the Importance of a Well-Rounded Fellowship Experience

Awards

Awards

Professional Memberships

Publications

Provider Profile: Abhinav Deol, M.D.

Abhinav Deol, M.D.

Locations

Karmanos Cancer Center

Provider Profile:
Abhinav Deol, M.D.